Trimel Pharmaceutica (TRLPF) Announces Quarterly Earnings, Beats Expectations By $0.02 EPS
Trimel Pharmaceutica (NASDAQ:TRLPF) announced its earnings results on Tuesday. The company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.02, Analyst RN reports.
Trimel Pharmaceutica (NASDAQ:TRLPF) opened at 0.641 on Tuesday. Trimel Pharmaceutica has a 52-week low of $0.34 and a 52-week high of $0.89. The stock has a 50-day moving average of $0.61 and a 200-day moving average of $0.59. The company’s market cap is $104.6 million.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.